Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TRAIDBTC

(TRAIDBTC)

Unknown symbol

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/02/2024	5:30PM	Business Wire	Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma	NASDAQ:GMAB	Genmab AS
06/02/2024	5:30PM	GlobeNewswire Inc.	Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma	TG:GE9	Genmab AS
06/02/2024	5:29PM	PR Newswire (Canada)	Bilan du Festival Go vélo Montréal 2024 - Une semaine parfaite pour (re)découvrir Montréal à vélo!
06/02/2024	5:28PM	GlobeNewswire Inc.	Le congrès de l’EAACI débute à Valence, en Espagne
06/02/2024	5:28PM	GlobeNewswire Inc.	Começa o Congresso da EAACI em Valência, Espanha
06/02/2024	5:28PM	GlobeNewswire Inc.	Auftakt zum EAACI-Kongress in Valencia, Spanien
06/02/2024	5:07PM	GlobeNewswire Inc.	Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
06/02/2024	5:07PM	GlobeNewswire Inc.	Las enfermedades alérgicas suponen un coste directo de entre 1.800 y 6.600 euros por paciente al año
06/02/2024	5:07PM	GlobeNewswire Inc.	Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
06/02/2024	5:01PM	PR Newswire (Canada)	Avis aux médias - Agenda public du premier ministre du Québec - 3 juin 2024
06/02/2024	5:00PM	PR Newswire (Canada)	Media Advisory - Deputy Prime Minister's itinerary for Monday, June 3, 2024
06/02/2024	5:00PM	PR Newswire (Canada)	Avis aux médias - Itinéraire de la vice-première ministre pour le lundi 3 juin 2024
06/02/2024	4:08PM	GlobeNewswire Inc.	In occasione di ASMS 2024, Biognosys lancia la rivoluzionaria tecnologia P2 Plasma Enrichment per la proteomica del plasma profonda e imparziale
06/02/2024	4:08PM	GlobeNewswire Inc.	Biognosys lance P2 Plasma Enrichment, une technologie révolutionnaire pour la protéomique approfondie et non biaisée du plasma à la conférence de l’ASMS 2024
06/02/2024	4:08PM	GlobeNewswire Inc.	Biognosys stellt auf der ASMS 2024 die bahnbrechende P2 Plasma-Anreicherungstechnologie für unverfälschte, tiefgehende Plasmaproteomik vor
06/02/2024	4:08PM	GlobeNewswire Inc.	Biognosys lanza en la conferencia anual de la ASMS 2024 la innovadora tecnología de enriquecimiento plasmático P2 para una proteómica plasmática profunda e imparcial
06/02/2024	4:00PM	PR Newswire (US)	FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
06/02/2024	3:45PM	PR Newswire (US)	izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
06/02/2024	3:00PM	PR Newswire (Canada)	Conférence de presse du ministre de la Justice et du ministre de la Sécurité publique
06/02/2024	2:53PM	PR Newswire (US)	GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
06/02/2024	2:32PM	Business Wire	TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial	NASDAQ:AZN	AstraZeneca PLC
06/02/2024	2:23PM	PR Newswire (Canada)	AVIS - Voie de contournement ferroviaire à Lac-Mégantic: point de presse de Christine Labrie et de groupes de la société civile
06/02/2024	1:00PM	PR Newswire (Canada)	/R E P E A T -- Media Advisory - Minister Wilkinson announces funding and measures to protect Southern Resident killer whales/
06/02/2024	1:00PM	PR Newswire (Canada)	/R E P R I S E -- Avis aux médias - Le ministre Wilkinson annonce des investissements et des mesures pour protéger les épaulards résidents du Sud/
06/02/2024	12:40PM	PR Newswire (US)	GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
06/02/2024	12:40PM	PR Newswire (Canada)	GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
06/02/2024	12:30PM	GlobeNewswire Inc.	Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting	NASDAQ:MRUS	Merus NV
06/02/2024	12:30PM	GlobeNewswire Inc.	Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting	TG:2GH	Merus NV
06/02/2024	12:30PM	GlobeNewswire Inc.	Merus : présentation des données provisoires sur le MCLA-145 en monothérapie et en association avec le pembrolizumab lors du congrès annuel 2024 de l’ASCO®	TG:2GH	Merus NV
06/02/2024	12:30PM	Business Wire	CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination

1 2 3 4 5 6 7 8 9 10 Next >>

Trump Media and Technology

Fannie Mae (QB)

Rennova Health (PK)

Net Savings Link (PK)

Lightwave Logic

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

AMC Entertainment

TPT Global Tech (PK)

Bioelectronics (PK)

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions